Unlearn advances AI technology to eliminate trial and error in medicine. They create AI-generated digital twins of patients that forecast individual health outcomes and are used to run clinical trials that reach full enrollment faster and bring new treatments to patients sooner. Unlearn's technology is regulatory-qualified and used by leading global pharmaceutical companies to accelerate clinical drug development.